During this phase, the goal shifts from active weight loss to preserving results, supporting insulin sensitivity, and maintaining long term metabolic health
A recent and more extensive ( N = 10,690 people with diabetes followed up over 67 years) historical cohort study observed a reduced association between GLP-1RA use compared with non-use for depressive and, more pronouncedly, anxiety disorders incidence, especially in women 32
[PubMed] Bruinstroop E, van der Spek AH, Boelen A
The Role of Light Activity Versus Structured Exercise While rigorous exercise is not required for GLP-1 weight loss, emerging evidence suggests light-to-moderate activitysuch as 20-30 minutes of walking most daysmay enhance outcomes and preserve lean muscle mass
In pregnant female rats given subcutaneous doses of 0.1, 0.25 and 1 mg/kg/day liraglutide from gestation day 6 through weaning or termination of nursing on lactation day 24, estimated systemic exposures were 0.8-, 3-, and 11-times exposure in obese humans at the MRHD of 3 mg/day, based on plasma AUC comparison
Months 6-18: sustained response The SURMOUNT-5 trial ran for 72 weeks (about 18 months) and showed continued weight loss throughout the study period for most tirzepatide users